+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Delivery Market - Global Forecast 2026-2032- Product Image
Drug Delivery Market - Global Forecast 2026-2032- Product Image
Sale

Drug Delivery Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083895
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Delivery Market is projected to reach USD 2.07 Trillion in 2026. It is expected to continue growing at a CAGR of 9.16%, reaching USD 3.52 Trillion by 2032.

Drug delivery is moving from a supporting function to a strategic value driver across pharmaceuticals, biotechnology, medtech, and specialty care. The sector is shaped by rising chronic disease prevalence, growth in biologics and biosimilars, demand for patient-centric care, and the need to improve adherence across oral, injectable, inhaled, transdermal, implantable, and targeted delivery platforms.

As drug pipelines shift toward complex molecules, drug delivery technologies increasingly determine product differentiation, lifecycle management, clinical outcomes, and commercial access.

Transformative Shifts in the Drug Delivery Landscape

The drug delivery landscape is being transformed by biologics, long-acting injectables, microneedles, connected autoinjectors, nanoparticle-based delivery, wearable pumps, and precision formulations designed to improve bioavailability and targeted release. Pharmaceutical companies are prioritizing delivery systems that reduce dosing frequency, support home-based care, and address adherence barriers documented across chronic disease management.

Regulatory expectations are also reshaping development strategies. Agencies such as the U.S. FDA and European Medicines Agency emphasize combination product quality, usability engineering, human factors testing, device reliability, and post-market safety monitoring. At the same time, payers are rewarding products that demonstrate measurable value, shifting competition from molecule-only innovation toward integrated drug-device-service models.

Cumulative Impact of Artificial Intelligence on Drug Delivery

Artificial intelligence is becoming a practical enabler across formulation development, pharmacokinetic modeling, device design, clinical trial optimization, manufacturing control, and patient support. AI-assisted modeling can help screen excipients, predict release profiles, identify stability risks, and accelerate design-of-experiments workflows while reducing avoidable laboratory iterations.

The strongest near-term impact is visible in connected drug delivery systems, where AI can support dose tracking, adherence analytics, adverse-event signal detection, and personalized intervention. However, industry leaders must treat AI as a validated, governed capability. Data integrity, algorithm transparency, cybersecurity, bias management, and compliance with GxP quality principles are essential for scaling AI in regulated drug delivery environments.

Key Regional Insights Across Global Drug Delivery Markets

Asia-Pacific is a high-growth drug delivery region supported by expanding healthcare access, strong pharmaceutical manufacturing in China and India, advanced device innovation in Japan and South Korea, and rising demand for diabetes, oncology, respiratory, and cardiovascular therapies. North America remains a leading hub for advanced drug delivery innovation due to FDA-regulated combination product development, strong clinical research infrastructure, specialty pharma investment, and high adoption of self-administered injectables and connected care models.

Europe benefits from mature reimbursement systems, EMA scientific guidance, strong formulation expertise, and sustainability-focused packaging and device requirements. Latin America, led by Brazil and Mexico, is advancing through biosimilar access, public procurement, and chronic disease treatment expansion. The Middle East is prioritizing localized pharmaceutical production and specialty care infrastructure, especially across GCC markets. Africa presents long-term opportunity for affordable, heat-stable, easy-to-use delivery formats that can help overcome cold-chain, access, and last-mile healthcare constraints.

Key Group Insights for Drug Delivery Strategy

ASEAN is gaining relevance as a drug delivery manufacturing and access corridor, with Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines supporting medtech production, healthcare expansion, and regional regulatory alignment. The GCC is emphasizing pharmaceutical localization, diabetes management, specialty care, and hospital modernization, making advanced injectables, inhalation therapies, and connected devices increasingly relevant.

The European Union remains influential through centralized drug approvals, medical device regulation, pharmacovigilance expectations, and environmental policy that affects packaging and device design. BRICS markets combine large patient populations, local manufacturing capacity, and public health demand, creating scale opportunities for cost-effective delivery technologies. G7 countries lead in R&D intensity, premium biologics, and digital health adoption, while NATO-linked health systems highlight the importance of resilient supply chains, medical readiness, and secure access to critical drug delivery products.

Key Country Insights Shaping Drug Delivery Demand

The United States leads in advanced drug delivery commercialization through specialty pharmaceuticals, biologics, connected devices, and FDA combination product pathways, while Canada emphasizes evidence-based reimbursement, chronic care, and patient safety. Mexico is strengthening its role in regional manufacturing and access, and Brazil remains Latin America’s largest pharmaceutical market with growing biosimilar and public health demand.

In Europe, the United Kingdom supports clinical research and health technology assessment, Germany anchors high-value pharmaceutical and device manufacturing, France prioritizes healthcare access and innovation, Italy and Spain contribute strong hospital networks and manufacturing capabilities, and Russia maintains demand for localized pharmaceutical supply despite geopolitical complexity. In Asia-Pacific, China offers scale, manufacturing depth, and rapid biopharma growth; India combines generics leadership with expanding biologics and device capabilities; Japan emphasizes quality, aging-related care, and advanced injectables; Australia supports clinical development and regulated access; and South Korea continues to advance biologics, biosimilars, and high-technology drug delivery platforms.

Actionable Recommendations for Drug Delivery Leaders

Industry leaders should prioritize platform-based delivery strategies that can support multiple molecules, indications, and lifecycle extensions. Investments in long-acting formulations, self-administration, connected delivery devices, and patient-friendly packaging can improve adherence while strengthening product differentiation in competitive therapeutic categories.

Executives should also align formulation, device engineering, regulatory, quality, market access, and digital health teams early in development. AI-enabled design and manufacturing should be deployed with validated data governance. Regional localization, resilient sourcing, sustainability compliance, and partnerships with contract development and manufacturing organizations, device specialists, and digital health providers will be critical for scaling globally.

Research Methodology

This executive summary is grounded in a structured methodology that triangulates verified secondary research, regulatory intelligence, clinical trial activity, patent trends, public health datasets, and expert interpretation. Sources considered include recognized authorities such as WHO, OECD, World Bank, FDA, EMA, national health agencies, peer-reviewed literature, and public regulatory documentation.

Insights are validated through cross-source comparison, segmentation logic, regional assessment, and consistency checks against known regulatory, manufacturing, and healthcare access dynamics. The methodology avoids unsupported claims and focuses on evidence-backed trends that influence drug delivery innovation, adoption, and competitive positioning.

Conclusion

Drug delivery is becoming one of the most important competitive frontiers in healthcare because it directly influences therapeutic performance, patient experience, adherence, and market access. As biologics, complex generics, precision medicine, and chronic disease therapies expand, delivery systems will play a larger role in determining clinical and commercial success.

Organizations that integrate advanced formulation science, device usability, AI-enabled development, regulatory excellence, and resilient global supply chains will be best positioned to capture value. The future of drug delivery will favor scalable, patient-centered, data-informed platforms that improve outcomes while meeting payer, provider, and regulatory expectations.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Drug Delivery Market, by Product Type
7.1. Introduction
7.2. Conventional Devices
7.3. Implantable Pumps
7.4. Microneedle Patches
7.5. Needle Free Injectors
7.6. Smart Systems
7.6.1. Connected Injector
7.6.2. Wearable Injector
8. Drug Delivery Market, by Product Type
8.1. Introduction
8.2. Infusion Pumps
8.2.1. Implantable Pumps
8.2.2. Insulin Pumps
8.2.3. PCA Pumps
8.3. Inhalers
8.4. Nasal Sprays
8.5. Ophthalmic Devices
8.6. Syringes
8.7. Transdermal Patches
9. Drug Delivery Market, by Technology
9.1. Introduction
9.2. Hydrogel System
9.3. Lipid Based Carrier
9.4. Liposome Carrier
9.5. Microneedle Technology
9.6. Nanoemulsion System
9.7. Polymer Based Carrier
10. Drug Delivery Market, by Therapeutic Area
10.1. Introduction
10.2. Cardiovascular Disorders
10.3. CNS Disorders
10.4. Diabetes
10.5. Oncology
10.6. Pain Management
10.7. Respiratory Disorders
11. Drug Delivery Market, by Formulation State
11.1. Introduction
11.2. Solid
11.3. Liquid
11.4. Semi Solid
11.5. Gaseous
12. Drug Delivery Market, by Patient Population
12.1. Introduction
12.2. Pediatric
12.3. Adult
12.4. Geriatric
13. Drug Delivery Market, by End User
13.1. Introduction
13.2. Ambulatory Surgical Center
13.3. Home Healthcare
13.4. Hospital
13.5. Specialty Clinic
14. Drug Delivery Market, by Route Of Administration
14.1. Introduction
14.2. Oral
14.3. Injectable
14.4. Pulmonary
14.5. Nasal
14.6. Ocular
14.7. Transdermal
14.8. Topical
15. Drug Delivery Market, by Region
15.1. Asia-Pacific
15.2. Europe
15.3. North America
15.4. Latin America
15.5. Africa
15.6. Middle East
16. Drug Delivery Market, by Group
16.1. NATO
16.2. G7
16.3. BRICS
16.4. European Union
16.5. ASEAN
16.6. GCC
17. Drug Delivery Market, by Country
17.1. China
17.2. United States
17.3. Japan
17.4. India
17.5. Germany
17.6. United Kingdom
17.7. Australia
17.8. France
17.9. South Korea
17.10. Italy
17.11. Canada
17.12. Russia
17.13. Brazil
17.14. Mexico
17.15. Spain
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. FPNV Positioning Matrix, 2025
18.3. Market Concentration Analysis, 2025
18.3.1. Concentration Ratio (CR)
18.3.2. Herfindahl Hirschman Index (HHI)
18.4. Recent Developments & Impact Analysis, 2025
18.5. Product Portfolio Analysis, 2025
18.6. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Abbott Laboratories
19.2. AbbVie Inc.
19.3. Alcon Vision LLC
19.4. Apotex Inc.
19.5. AptarGroup, Inc.
19.6. Bausch Health Companies Inc.
19.7. Bayer AG
19.8. Carl Zeiss AG
19.9. Crescita Therapeutics Inc.
19.10. DifGen Pharmaceuticals LLC
19.11. DuPont de Nemours, Inc.
19.12. Element Materials Technology
19.13. EyePoint Pharmaceuticals, Inc.
19.14. F. Hoffmann-La Roche AG
19.15. Galderma SA
19.16. Genentech, Inc.
19.17. Gerresheimer AG
19.18. GlaxoSmithKline plc
19.19. Hisamitsu Pharmaceutical Co.,Inc.
19.20. Iskon Remedies
19.21. Johnson & Johnson Services, Inc.
19.22. Kindeva Drug Delivery L.P.
19.23. LEO Pharma A/S
19.24. Lubrizol Corporation
19.25. Lupin Limited
19.26. Mati Therapeutics, Inc.
19.27. MedPharm Group Ltd.
19.28. Merck & Co., Inc.
19.29. Merck KGaA
19.30. MgShell S.R.L.
19.31. Nicox SA
19.32. Novartis AG
19.33. Ocular Therapeutix Inc.
19.34. Oculis SA
19.35. Pfizer Inc.
19.36. Porex Corporation
19.37. Recipharm AB
19.38. Regeneron Pharmaceuticals, Inc.
19.39. Santen Pharmaceutical Co., Ltd.
19.40. Sun Pharmaceutical Industries, Inc.
19.41. Terumo Corporation
19.42. Teva Pharmaceutical Industries Ltd.
List of Figures
FIGURE 1. GLOBAL DRUG DELIVERY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL DRUG DELIVERY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL DRUG DELIVERY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL DRUG DELIVERY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL DRUG DELIVERY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2032 (%)
FIGURE 13. GLOBAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL DRUG DELIVERY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 19. GLOBAL DRUG DELIVERY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL DRUG DELIVERY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL DRUG DELIVERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL DRUG DELIVERY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 25. GLOBAL DRUG DELIVERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 27. GLOBAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 29. GLOBAL DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL DRUG DELIVERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CONVENTIONAL DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CONVENTIONAL DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CONVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL IMPLANTABLE PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL IMPLANTABLE PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL IMPLANTABLE PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL MICRONEEDLE PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL MICRONEEDLE PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL MICRONEEDLE PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL NEEDLE FREE INJECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL NEEDLE FREE INJECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL NEEDLE FREE INJECTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL SMART SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL SMART SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL SMART SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL CONNECTED INJECTOR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL CONNECTED INJECTOR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL CONNECTED INJECTOR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL INFUSION PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL INFUSION PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL INFUSION PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL IMPLANTABLE PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL IMPLANTABLE PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL IMPLANTABLE PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL INSULIN PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL INSULIN PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL PCA PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL PCA PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL PCA PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL INHALERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL INHALERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL INHALERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL NASAL SPRAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL NASAL SPRAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL NASAL SPRAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL OPHTHALMIC DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL SYRINGES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL SYRINGES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL SYRINGES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL HYDROGEL SYSTEM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL HYDROGEL SYSTEM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL HYDROGEL SYSTEM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL LIPID BASED CARRIER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL LIPID BASED CARRIER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL LIPID BASED CARRIER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL LIPOSOME CARRIER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL LIPOSOME CARRIER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL LIPOSOME CARRIER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL MICRONEEDLE TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL MICRONEEDLE TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL MICRONEEDLE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL NANOEMULSION SYSTEM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL NANOEMULSION SYSTEM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL NANOEMULSION SYSTEM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL POLYMER BASED CARRIER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL POLYMER BASED CARRIER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL POLYMER BASED CARRIER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL CARDIOVASCULAR DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL CARDIOVASCULAR DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL CARDIOVASCULAR DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CNS DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL CNS DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL CNS DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL RESPIRATORY DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL SOLID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL SOLID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL SOLID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL LIQUID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL LIQUID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL LIQUID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL SEMI SOLID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL SEMI SOLID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL SEMI SOLID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL GASEOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL GASEOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL GASEOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL AMBULATORY SURGICAL CENTER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL AMBULATORY SURGICAL CENTER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL AMBULATORY SURGICAL CENTER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL HOME HEALTHCARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL HOME HEALTHCARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL HOME HEALTHCARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL HOSPITAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL HOSPITAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL HOSPITAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL SPECIALTY CLINIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL SPECIALTY CLINIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL SPECIALTY CLINIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL PULMONARY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL PULMONARY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL PULMONARY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL NASAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL NASAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL NASAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL OCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL OCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL OCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL TRANSDERMAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL TRANSDERMAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL TRANSDERMAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL DRUG DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 161. EUROPE DRUG DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 162. EUROPE DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 163. EUROPE DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 164. EUROPE DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 165. EUROPE DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 166. EUROPE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 167. EUROPE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 168. EUROPE DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 169. EUROPE DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 170. EUROPE DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 171. EUROPE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 172. NORTH AMERICA DRUG DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 173. NORTH AMERICA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 174. NORTH AMERICA DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 175. NORTH AMERICA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 176. NORTH AMERICA DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 177. NORTH AMERICA DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 178. NORTH AMERICA DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 179. NORTH AMERICA DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 180. NORTH AMERICA DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 181. NORTH AMERICA DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 182. NORTH AMERICA DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 183. LATIN AMERICA DRUG DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 184. LATIN AMERICA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 185. LATIN AMERICA DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 186. LATIN AMERICA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 187. LATIN AMERICA DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 188. LATIN AMERICA DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 189. LATIN AMERICA DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 190. LATIN AMERICA DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 191. LATIN AMERICA DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 192. LATIN AMERICA DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 193. LATIN AMERICA DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 194. AFRICA DRUG DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 195. AFRICA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 196. AFRICA DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 197. AFRICA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 198. AFRICA DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 199. AFRICA DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 200. AFRICA DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 201. AFRICA DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 202. AFRICA DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 203. AFRICA DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 204. AFRICA DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 205. MIDDLE EAST DRUG DELIVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 206. MIDDLE EAST DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 207. MIDDLE EAST DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 208. MIDDLE EAST DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 209. MIDDLE EAST DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 210. MIDDLE EAST DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 211. MIDDLE EAST DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 212. MIDDLE EAST DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 213. MIDDLE EAST DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 214. MIDDLE EAST DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 215. MIDDLE EAST DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 216. GLOBAL DRUG DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 217. NATO DRUG DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 218. NATO DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 219. NATO DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 220. NATO DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 221. NATO DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 222. NATO DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 223. NATO DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 224. NATO DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 225. NATO DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 226. NATO DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 227. NATO DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 228. G7 DRUG DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 229. G7 DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 230. G7 DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 231. G7 DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 232. G7 DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 233. G7 DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 234. G7 DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 235. G7 DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 236. G7 DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 237. G7 DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. G7 DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 239. BRICS DRUG DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 240. BRICS DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 241. BRICS DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 242. BRICS DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 243. BRICS DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 244. BRICS DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 245. BRICS DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 246. BRICS DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 247. BRICS DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 248. BRICS DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 249. BRICS DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION DRUG DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 261. ASEAN DRUG DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 262. ASEAN DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 263. ASEAN DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 264. ASEAN DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 265. ASEAN DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 266. ASEAN DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 267. ASEAN DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 268. ASEAN DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 269. ASEAN DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 270. ASEAN DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 271. ASEAN DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 272. GCC DRUG DELIVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 273. GCC DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 274. GCC DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 275. GCC DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 276. GCC DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 277. GCC DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 278. GCC DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 279. GCC DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 280. GCC DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 281. GCC DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 282. GCC DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 283. GLOBAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 284. CHINA DRUG DELIVERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 285. CHINA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 286. CHINA DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 287. CHINA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 288. CHINA DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 289. CHINA DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 290. CHINA DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 291. CHINA DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 292. CHINA DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 293. CHINA DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 294. CHINA DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 295. UNITED STATES DRUG DELIVERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 296. UNITED STATES DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 297. UNITED STATES DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 298. UNITED STATES DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 299. UNITED STATES DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 300. UNITED STATES DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 301. UNITED STATES DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 302. UNITED STATES DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 303. UNITED STATES DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 304. UNITED STATES DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 305. UNITED STATES DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 306. JAPAN DRUG DELIVERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 307. JAPAN DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 308. JAPAN DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 309. JAPAN DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 310. JAPAN DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 311. JAPAN DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 312. JAPAN DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 313. JAPAN DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 314. JAPAN DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 315. JAPAN DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 316. JAPAN DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 317. INDIA DRUG DELIVERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 318. INDIA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 319. INDIA DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 320. INDIA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 321. INDIA DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 322. INDIA DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 323. INDIA DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 324. INDIA DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 325. INDIA DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 326. INDIA DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 327. INDIA DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 328. GERMANY DRUG DELIVERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 329. GERMANY DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 330. GERMANY DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 331. GERMANY DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 332. GERMANY DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 333. GERMANY DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 334. GERMANY DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 335. GERMANY DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 336. GERMANY DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 337. GERMANY DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 338. GERMANY DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 339. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 340. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 341. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 342. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 343. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 344. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 345. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 346. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 347. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 348. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 349. UNITED KINGDOM DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 350. AUSTRALIA DRUG DELIVERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 351. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 352. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 353. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 354. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 355. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 356. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 357. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 358. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 359. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 360. AUSTRALIA DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 361. FRANCE DRUG DELIVERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 362. FRANCE DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 363. FRANCE DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 364. FRANCE DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 365. FRANCE DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 366. FRANCE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 367. FRANCE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 368. FRANCE DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 369. FRANCE DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 370. FRANCE DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 371. FRANCE DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 372. SOUTH KOREA DRUG DELIVERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 373. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 374. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY SMART SYSTEMS, 2017-2032 (USD MILLION)
TABLE 375. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 376. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, 2017-2032 (USD MILLION)
TABLE 377. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 378. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 379. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY FORMULATION STATE, 2017-2032 (USD MILLION)
TABLE 380. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY PATIENT POPULATION, 2017-2032 (USD MILLION)
TABLE 381. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 382. SOUTH KOREA DRUG DELIVERY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 383. ITALY DRUG DELIVERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 384. ITALY DRUG DELIVERY MARKET SIZE, BY PRODU

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Alcon Vision LLC
  • Apotex Inc.
  • AptarGroup, Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Carl Zeiss AG
  • Crescita Therapeutics Inc.
  • DifGen Pharmaceuticals LLC
  • DuPont de Nemours, Inc.
  • Element Materials Technology
  • EyePoint Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche AG
  • Galderma SA
  • Genentech, Inc.
  • Gerresheimer AG
  • GlaxoSmithKline plc
  • Hisamitsu Pharmaceutical Co.,Inc.
  • Iskon Remedies
  • Johnson & Johnson Services, Inc.
  • Kindeva Drug Delivery L.P.
  • LEO Pharma A/S
  • Lubrizol Corporation
  • Lupin Limited
  • Mati Therapeutics, Inc.
  • MedPharm Group Ltd.
  • Merck & Co., Inc.
  • Merck KGaA
  • MgShell S.R.L.
  • Nicox SA
  • Novartis AG
  • Ocular Therapeutix Inc.
  • Oculis SA
  • Pfizer Inc.
  • Porex Corporation
  • Recipharm AB
  • Regeneron Pharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Sun Pharmaceutical Industries, Inc.
  • Terumo Corporation
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.07 Trillion
Forecasted Market Value ( USD ) by 2032 $ 3.52 Trillion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned42

Related Topics

Related Reports

Electronic Drug Delivery System Market - Global Forecast 2026-2032 - Product Image

Electronic Drug Delivery System Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Drug Delivery Devices Market - Global Forecast 2026-2032 - Product Image

Drug Delivery Devices Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Connected Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Connected Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Electronic Drug Delivery Systems - Global Strategic Business Report - Product Image

Electronic Drug Delivery Systems - Global Strategic Business Report

  • Report
  • 288 Pages
  • Global
From

About the Market

The Drug Delivery market is a sector of the pharmaceutical industry that focuses on the development and manufacture of drug delivery systems. These systems are designed to deliver drugs to the body in a safe and effective manner. Drug delivery systems can include oral, topical, injectable, and inhalable forms. They can also include transdermal patches, implants, and other devices. Drug delivery systems are designed to improve the efficacy of drugs, reduce side effects, and improve patient compliance. They can also be used to target specific areas of the body, such as the lungs or the brain. Some of the leading companies in the Drug Delivery market include Pfizer, Novartis, Merck, and Johnson & Johnson. Other companies include Sanofi, GlaxoSmithKline, and AstraZeneca. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.